These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 34755666)

  • 1. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
    Li Y; Wu D; Wei C; Yang X; Zhou S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
    Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q
    Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang WX; Pan YY; You CG
    Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1.
    Hao L; Li S; Chen G; Nie A; Zeng L; Xiao Z; Hu X
    Chem Biol Drug Des; 2024 Jun; 103(6):e14567. PubMed ID: 38858165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
    Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
    Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
    [No Abstract]   [Full Text] [Related]  

  • 10. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
    Zou Y; Ruan S; Jin L; Chen Z; Han H; Zhang Y; Jian Z; Lin Y; Shi N; Jin H
    Med Sci Monit; 2020 Aug; 26():e925289. PubMed ID: 32863381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
    Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
    Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
    Li S; Hao L; Hu X; Li L
    Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying a Three-Gene Signature and Associated Drugs for Hepatitis B Virus-Related Hepatocellular Carcinoma Using Comprehensive Bioinformatics Analysis.
    Tan Y; Zhang M; Chen X; Deng Y
    Tohoku J Exp Med; 2022 Sep; 258(2):149-157. PubMed ID: 36002253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
    Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
    Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis.
    Wang C; Xie X; Li W; Jiang D
    J Clin Lab Anal; 2022 Sep; 36(9):e24647. PubMed ID: 35949045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
    Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.